Hemogenyx Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Hemogenyx Pharmaceuticals does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-27.1%
Buyback Yield
| Total Shareholder Yield | -27.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?
Aug 21
Will Hemogenyx Pharmaceuticals (LON:HEMO) Spend Its Cash Wisely?
May 04We Think Hemogenyx Pharmaceuticals (LON:HEMO) Needs To Drive Business Growth Carefully
Jan 06Hemogenyx Pharmaceuticals (LON:HEMO) Has Debt But No Earnings; Should You Worry?
Oct 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if HEMO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HEMO's dividend payments have been increasing.
Dividend Yield vs Market
| Hemogenyx Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HEMO) | n/a |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.9% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (HEMO) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate HEMO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HEMO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate HEMO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HEMO has not reported any payouts.